⌕
National Health Investors · NHI · NYSE
Tenet 45 · Mixed
Compare
$60.77−3.46%At closeTenet 45 · Mixed
$60.77−2.18 (−3.46%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

National Health Investors (NHI) Earnings Forecast

Analysts expect National Health Investors (NHI) to earn $5.79 a share in FY26, the average of 4 estimates as of Nov 13, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice
FY26 consensus EPS
$5.79
4 analysts
FY27 consensus EPS
$3.15
3 analysts · low $3.10, high $3.18
EPS revisions, 30 days
+48.8%
$3.89 to $5.79
Disagreement, FY26
1.5%
high to low, $5.76 to $5.84

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 13, 2026 · we check it nightly
Forward P/E · FY26E
10.9×
$62.95 (as of close, Nov 13, 2026) ÷ $5.79 consensus EPS
Coverage · FY26
4 · 3
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $5.79, up 54.4% in 91 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 91 days. One step per nightly change.

−16.5%+24.4%+65.2%FY26 +54.4%FY27 −4.1%Aug 15Nov 13
EPS30 days90 daysshown aboveSince Jul 6
FY264 analysts▲ +48.8%$3.89 to $5.79▲ +54.4%$3.75 to $5.79▲ +64.4%$3.52 to $5.79
FY273 analysts▼ −2.4%$3.23 to $3.15▼ −4.1%$3.28 to $3.15▼ −6.5%$3.37 to $3.15
Sep '262 analysts◆ 0.0%$1.18 to $1.18▼ −22.6%$1.53 to $1.18▼ −10.0%$1.32 to $1.18
Dec '261 analyst▼ −3.5%$0.74 to $0.71▼ −9.5%$0.79 to $0.71▼ −9.5%$0.79 to $0.71

Contributors at both ends of the window: FY26 2 and 4. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 13, 2026 · consensus as of Nov 13, 2026

At 20.8 times earnings, which is what National Health Investors trades at today, the FY27 consensus of $3.15 works out to $66 a share.

Consensus EPS · FY27
$3.15
3 analysts · low $3.10, high $3.18 · thin coverage
Multiple · today's trailing P/E
20.8×
$62.95 (as of close, Nov 13, 2026) ÷ $3.02 FY25 EPS computed by Tenet
×
Receipt · NHI · FY27Nov 13, 2026
Implied, a share
$66

Range on the low and high estimate: $65 to $66.

$65 low$66 high
3.15 × 20.8, to the dollar
Drag the multipleShaded: where National Health Investors' P/E sat at each fiscal year end, FY08 to FY25. Each dot is one year.
11×15×20×25×30×35×39×
today 20.8×10-yr median 21.4×5-yr avg 24.8×$66 a share

Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 10.9 times the FY26 consensus for earnings the Street expects to shrink about 25% a year to FY28. A falling number is not a growth rate, so the multiple is not divided by it here.Show today's multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY08 to FY25 · over 18 fiscal years. The mark is the median of the last 10.
20.8× today
13.2× low35.2× high
21.4× median
Forward 10.9× is a different measure, so it is not placed on a trailing record. Today's mark is the trailing 20.8×, on the same basis as every year behind it.

How much do analysts disagree?

For FY29, estimates run from $3.27 to $3.55 around an average of $3.40, drawn by 1 analyst.

FY26E4 analysts
$5.76 to $5.84 · 1.5%
FY27E3 analysts
$3.10 to $3.18 · 2.4%
FY28E2 analysts
$3.16 to $3.33 · 5.4%
FY29E1 analyst
$3.27 to $3.55 · 8.1%

The dashed line is FY25 filed $3.02, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect National Health Investors to earn $0.71 a share in the December quarter, the one estimate published. We hold no expected date for the next report. Last quarter, which ended in June, National Health Investors earned $1.15 a share. Analysts had expected $0.84, so it came in 36.4% higher.

$0.80
$0.71high $0.72
low $0.70
−11.0%crosses bases
Dec 2025 quarterfiled · GAAPDec 2026 quarterconsensus · Street basis · 1 analyst
Expected report
Not held
No expected date is published for this company's next report, so none is printed here.
Revenue expected · December quarter
$66.2M
3 analysts, 64.6 to 68.2 in $M · 105.7 in the same quarter a year ago

The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. For the March quarter, analysts expect $0.74 a share.

Does National Health Investors usually beat or miss?

So far we have checked 10 quarters, of which 8 came in above the estimate we held. We add a quarter to this record each time National Health Investors reports.

We started recording estimates on Jul 6, 2026, so quarters that reported before that date cannot be checked.

Before our record
Dec '23
Our record, one quarter per report
+4.7%
Mar '24reaction
+2.2%
+12.0%
Jun '24reaction
+0.4%
−11.1%
Sep '24reaction
0.0%
+29.7%
Dec '24reaction
−0.2%
+1.4%
Mar '25reaction
+0.4%
+5.5%
Jun '25reaction
+2.5%
+0.8%
Sep '25reaction
+2.0%
+1.2%
Dec '25reaction
−4.1%
−4.0%
Mar '26reaction
−3.5%
+36.4%
Jun '26reaction
−5.7%
Sep '26left out · basis
Dec '26not reported yet
Checked so far
10 quarters
one more every report
Beat expectations
8 of 10
full details on the Earnings tab
Share price reaction
−0.6%
the average over all 10 checked quarters, one session each, timed to each release
Typical gap vs estimate
+3.1%
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for National Health Investors on Jul 6, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Mar '24, Jun '24, Sep '24, Dec '24, Mar '25, Jun '25, Sep '25, Dec '25, Mar '26 are drawn hollow: we hold no estimate for those quarters recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.

The Street expects sales to grow −2.1% in FY27 and EPS −45.6%. The net margin moves from 98.3% to 54.3%, and the implied share count from about 47.1M to 46.9M, so these numbers assume the count keeps falling.Show the decomposition and the margin ladderHide the decomposition
FY27 EPS growth, in points
Revenue growth−2.1
Net margin change−43.8
Share count change+0.3
EPS growth−45.6
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
4 analysts publish an EPS estimate for FY26 and 3 publish revenue. Coverage thins with distance: 0 EPS estimates for FY30. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
34
FY26E
33
FY27E
32
FY28E
11
FY29E
20
FY30E
The FY26 panel held 3 analysts when our record of it began on Jul 6, 2026 and holds 4 tonight.

The full consensus, year by year

Consensus as of Nov 13, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
0.20.30.4historyStreet forecastFY22FY25FY30E

Coverage thins with distance: 3 revenue estimates for FY26, 2 for FY30.

Diluted EPS · $filed · consensus average · band = low to high
1.223.626.02historyStreet forecastFY22FY25FY29E

Out-year bands widen as fewer analysts publish: 4 EPS estimates for FY26, 0 for FY30.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed0.4—3.02————as filed20.8×
FY26E0.30.3 to 0.3▼26.1%a5.795.76 to 5.84▲91.9%a0.50.30.053 · 410.9×
FY27E0.30.3 to 0.3▼2.1%3.153.10 to 3.18▼45.6%0.30.10.053 · 320.0×
FY28E0.30.3 to 0.3▲0.7%3.243.16 to 3.33▲2.9%0.30.20.053 · 219.4×
FY29E0.30.3 to 0.3n/cb3.403.27 to 3.55n/cb0.30.20.051 · 118.5×
FY30E0.30.3 to 0.3n/cb—————2 · 0—

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over that year's filed EPS, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 4 EPS estimates for FY26, 3 for revenue. Not investment advice.

What do analysts expect National Health Investors to earn in FY26?

Analysts expect National Health Investors to earn $5.79 a share in FY26, the average of 4 estimates as of Nov 13, 2026.

What is National Health Investors' earnings forecast for FY27?

The FY27 consensus for National Health Investors is $3.15 a share from 3 analysts, with a low of $3.10 and a high of $3.18, as of Nov 13, 2026.

Have analysts raised National Health Investors' earnings estimates?

National Health Investors' FY26 EPS consensus rose 54.4% in 91 days, from $3.75 to $5.79, as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.